Simplify Logo

Full-Time

Scientist I

Computational Biology, Cancer Biology

Posted on 2/8/2024

Revolution Medicines

Revolution Medicines

201-500 employees

Specializes in precision oncology therapies

Hardware
Biotechnology
Healthcare

Compensation Overview

$120k - $145kAnnually

Junior

San Carlos, CA, USA

Category
Biology & Biotech
Required Skills
Python
R
Requirements
  • Ph.D. in bioinformatics, genetics, or related field
  • 1+ years of experience with a focus on the analysis of NGS data
  • Expertise in statistical methods as applied to high-throughput biological experiments
  • Strong knowledge of molecular biology and genomics
  • Proficiency using R, Python, Julia, or equivalent
  • Strong scientific communication skills
Responsibilities
  • Work closely with experimental scientists to design, prioritize and develop computational analysis plans
  • Employ expertise to provide a biological interpretation of complex datasets
  • Explore and integrate multi-omic datasets including whole exome sequencing, copy number calling, bulk transcriptomics, single cell omcis and spatially resolved omics
  • Contribute to the development of analysis pipelines and computational tools
  • Work closely with scientists, contract research organizations, and other collaborators to answer key questions related to research
  • Communicate effectively the results of work to internal and external stakeholders

### Welcome to Revolution Medicines, crafting the future of oncology with precision. Our focus is on advancing RAS(ON) inhibitors and RAS Companion inhibitors, marked by the remarkable journey of our lead product, RMC-4630, through its clinical phases. Supported by a team of passionate oncology experts, we are steadfast in our mission to develop treatments that precisely target oncogenic mutations, promising a brighter, healthier tomorrow for patients everywhere. ###

Company Stage

IPO

Total Funding

$1.3B

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

17%

1 year growth

46%

2 year growth

111%
INACTIVE